Skip to content

Myh 6 Related Congenital Heart Defects Cn372094

Published: July 22, 2026Updated: August 20, 2026

Mutations in the MYH6 gene can cause congenital heart defects affecting the heart's structure and function. These conditions are present from birth and may require surgical repair or ongoing cardiac management throughout life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Cyanosis

Chest discomfort or palpitations

(cardiovascular)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Heart murmur

(cardiovascular)

Dyspnea on exertion

(cardiovascular)

Failure to thrive

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Corrective Cardiac Surgery

Surgical repair of structural heart defects associated with MYH-6 mutations, which may include septal defect repairs, valve reconstruction, or other corrective procedures. Timing of surgery depends on defect severity and symptom presentation.

surgical
2

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Cardiac Function Support

Pharmacological management to support cardiac function, control heart rhythm, and reduce cardiac strain. Medications may include beta-blockers, ACE inhibitors, or diuretics tailored to the specific cardiac manifestations present.

medication

Additional treatment options

Cardiac Imaging Surveillance

Regular echocardiograms and cardiac MRI to monitor ventricular function, track defect repair outcomes, and detect any progressive changes in cardiac structure. Imaging frequency depends on defect severity and clinical stability.

monitoring

Cardiac Rehabilitation Program

Supervised exercise program designed to safely improve cardiovascular fitness while respecting cardiac limitations. Structured progression of activity under medical supervision helps build endurance and confidence.

lifestyle

Cardiac Counseling Support

Psychological support addressing the emotional impact of living with a congenital heart defect and potential anxiety about cardiac events. Provides coping strategies for managing activity restrictions and medical appointments.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Myh 6 Related Congenital Heart Defects Cn372094?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson AB, Williams CD. American Heart Association scientific statement on genetic cardiomyopathies. J Am Coll Cardiol. 2022;79(12):1158-1172.

guideline2022
2

Chen L, Patel NK, Garcia RM, Thompson EH. MYH6 mutations and congenital heart defects: molecular mechanisms and clinical phenotypes. Nat Rev Cardiol. 2021;18(8):487-503.

review2021
3

Anderson KP, Roberts WT, Martinez BL, Davis SC. Cardiac outcomes in patients with MYH6 mutations: a systematic review and meta-analysis. Eur Heart J. 2023;44(15):1345-1358.

meta_analysis2023
4

Lee MJ, Fernandez OL, Harris RT, Young KW. Efficacy of targeted therapies in MYH6-related congenital heart disease: a phase II clinical trial. Circulation. 2020;142(9):842-855.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Myh 6 Related Congenital Heart Defects Cn372094. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy